Phase 3 Oligometastatic Clinical Trials
12 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–12 of 12 trials
Recruiting
Phase 3
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals450 enrolled142 locationsNCT05939414
Recruiting
Phase 3
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
Pancreas CancerOligometastatic
M.D. Anderson Cancer Center80 enrolled1 locationNCT06593431
Recruiting
Phase 3
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
Oligometastatic Squamous Cell Carcinoma of the Head and Neck
European Organisation for Research and Treatment of Cancer - EORTC200 enrolled26 locationsNCT05815927
Recruiting
Phase 3
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Stage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8Biochemically Recurrent Prostate Carcinoma+4 more
Mayo Clinic118 enrolled6 locationsNCT06205316
Recruiting
Phase 3
Total RadIoTherapy of Oligometastatic caNcerS
Oligometastatic Malignant Solid Neoplasm
University of California, San Diego300 enrolled1 locationNCT06587490
Recruiting
Phase 3
First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.
Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Gustave Roussy, Cancer Campus, Grand Paris124 enrolled3 locationsNCT06840782
Recruiting
Phase 3
Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC
Oligometastatic DiseaseMetastatic Non Small Cell Lung Cancer
Tata Memorial Hospital190 enrolled1 locationNCT05278052
Recruiting
Phase 2Phase 3
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
Oligometastatic Prostate Cancer
RenJi Hospital120 enrolled1 locationNCT06972511
Recruiting
Phase 3
PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer
Oligometastatic Gastric Adenocarcinoma
Azienda Ospedaliera Universitaria Integrata Verona98 enrolled1 locationNCT05303714
Recruiting
Phase 2Phase 3
Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care
Oligometastatic Disease
National Medical Research Radiological Centre of the Ministry of Health of Russia100 enrolled1 locationNCT06556550
Recruiting
Phase 3
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Prostate CancerMetastatic CancerProstate Cancer Metastatic+4 more
Universitaire Ziekenhuizen KU Leuven873 enrolled1 locationNCT05352178
Recruiting
Phase 3
Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
Esophageal Squamous Cell CarcinomaOligometastatic DiseaseRadiotherapy
Fudan University354 enrolled1 locationNCT06190782